CRISPR/Cas as a tool to overcome drug resistance in cancer: From challenge to opportunity
Drug resistance remains a significant challenge in cancer therapy, often resulting in treatment failure, tumor progression, and metastasis. The underlying resistance mechanisms—including genetic mutations, epigenetic alterations, and modifications in drug efflux pathways—are complex and not yet full...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2025-12-01
|
| Col·lecció: | Molecular and Cellular Probes |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S0890850825000453 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|